Published in Life Sci on January 01, 1989
Alcohol challenge responses predict future alcohol use disorder symptoms: a 6-year prospective study. Biol Psychiatry (2013) 2.01
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci (2005) 1.16
Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci (2001) 1.09
Endogenous opioids and excessive alcohol consumption. J Psychiatry Neurosci (1993) 0.98
Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol Alcohol (2009) 0.97
Alcoholism: the role of different motivational systems. J Psychiatry Neurosci (1995) 0.94
Confirmation of quantitative trait loci for ethanol sensitivity and neurotensin receptor density in crosses derived from the inbred high and low alcohol sensitive selectively bred rat lines. Psychopharmacology (Berl) (2006) 0.86
Interaction between family history of alcoholism and Locus of Control in the opioid regulation of impulsive responding under the influence of alcohol. Alcohol Clin Exp Res (2011) 0.84
Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats. Psychopharmacology (Berl) (2012) 0.82
Locomotor sensitization to EtOH: contribution of β-Endorphin. Front Mol Neurosci (2012) 0.82
Beta-endorphin mediates behavioral despair and the effect of ethanol on the tail suspension test in mice. Alcohol Clin Exp Res (2010) 0.81
The role of endogenous beta-endorphin and enkephalins in ethanol reward. Neuropharmacology (2013) 0.78
Biphasic effects of moderate drinking on prolactin during lactation. Alcohol Clin Exp Res (2008) 0.77
β-endorphin regulates alcohol consumption induced by exercise restriction in female mice. Alcohol (2016) 0.75
Differential expression of guanosine triphosphate binding proteins in men at high and low risk for the future development of alcoholism. J Clin Invest (1994) 0.75
Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci (1996) 2.57
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol (1997) 2.38
A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ (2000) 2.11
Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes. J Psychiatry Neurosci (1993) 2.02
A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies. J Antimicrob Chemother (1994) 1.64
TRPV4 channels mediate the infrared laser-evoked response in sensory neurons. J Neurophysiol (2012) 1.45
Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol (1999) 1.38
High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology (2003) 1.30
Understanding triclabendazole resistance. Exp Mol Pathol (2007) 1.28
Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch Gen Psychiatry (1996) 1.26
Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci (2002) 1.22
Prevalence of epilepsy in rural Bolivia: a door-to-door survey. Neurology (1999) 1.21
HTLV-I in Burundi (east Africa): lack of reactivity to the HTLV-I immunodominant envelope epitope. J Acquir Immune Defic Syndr (1994) 1.16
Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy. Epilepsia (1996) 1.15
Acute or subacute alcoholic neuropathy mimicking Guillain-Barré syndrome. J Neurol Sci (1990) 1.13
Headache and cysticercosis in Ecuador, South America. Headache (1995) 1.12
Expression and function of aquaporins in human skin: Is aquaporin-3 just a glycerol transporter? Biochim Biophys Acta (2006) 1.10
Estimation of the prevalence of epilepsy in the Benin region of Zinvié using the capture-recapture method. Int J Epidemiol (2000) 1.08
Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology (1987) 1.06
Retrograde axonal transport of specific macromolecules as a tool for characterizing nerve terminal membranes. J Neurobiol (1979) 1.06
An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg (2005) 1.04
Pasteurella multocida septicemia and peritonitis in a cirrhotic cock trainer with a pet pig. N Engl J Med (1980) 1.03
Oligodendroglial pathology in canine distemper virus infection in vitro. Acta Neuropathol (1987) 1.03
Influence of asiatic acid, madecassic acid, and asiaticoside on human collagen I synthesis. Planta Med (1994) 1.02
Antiepileptic therapies in the Mifi Province in Cameroon. Epilepsia (2000) 1.01
Secondary degeneration of oligodendrocytes in canine distemper virus infection in vitro. Lab Invest (1986) 1.01
Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol (1995) 1.01
Low human T cell leukemia virus type II seroprevalence in Africa. J Infect Dis (1994) 1.00
Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia (1996) 1.00
Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology (1997) 0.99
Sign language and multisensory input training of children with communication and related developmental disorders. J Autism Child Schizophr (1977) 0.99
[Study of antiglycolipid antibodies in IgM monoclonal dysglobulinemias associated with peripheral neuropathy]. Rev Neurol (Paris) (1988) 0.98
Effect of melarsoprol treatment on circulating IL-10 and TNF-alpha levels in human African trypanosomiasis. Clin Immunol Immunopathol (1997) 0.98
HIV-2 antibodies in African with spastic paraplegia. Lancet (1988) 0.97
Neurocysticercosis: validity of ELISA after storage of whole blood and cerebrospinal fluid on paper. Trop Med Int Health (2001) 0.96
Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol (2003) 0.96
Central brain postembryonic development in Drosophila: implication of genes expressed at the interhemispheric junction. J Neurobiol (2000) 0.94
Central motor conduction in motor neuron disease. Ann Neurol (1987) 0.94
BalI and MspI polymorphisms of the dopamine D3 receptor gene in African Blacks and Caucasians. Hum Hered (1996) 0.94
Canine distemper virus does not infect oligodendrocytes in vitro. J Neurol Sci (1985) 0.92
Effect of megazol on Trypanosoma brucei brucei acute and subacute infections in Swiss mice. Acta Trop (1995) 0.91
Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders. Exp Parasitol (1997) 0.91
Inducible nitric oxide synthase and nitrotyrosine in the central nervous system of mice chronically infected with Trypanosoma brucei brucei. Exp Parasitol (2000) 0.90
A monoclonal antibody that binds to both astrocytes and myelin sheaths. J Neuroimmunol (1985) 0.90
Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France. Neuroepidemiology (2000) 0.90
Implication of the endogenous opioid system in excessive ethanol consumption. Alcohol (1996) 0.90
A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Parasitology (2009) 0.90
Assessment of linear measurements of bone for implant sites in the presence of metallic artefacts using cone beam computed tomography and multislice computed tomography. Int J Oral Maxillofac Surg (2011) 0.89
Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic. Am J Epidemiol (1999) 0.89
Seroprevalence of cysticercosis in Bénin. Trans R Soc Trop Med Hyg (1999) 0.88
The duality of sleeping sickness: focusing on sleep. Sleep Med Rev (2001) 0.88
Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet (1993) 0.88
Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology (1988) 0.87
Megazol combined with suramin: a chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice. Trop Med Int Health (1998) 0.87
[Subacute sclerosing panencephalitis: electroencephalographic study (9 cases)]. Bull Soc Med Afr Noire Lang Fr (1970) 0.87
Sleep-wake cycle in human African trypanosomiasis. J Clin Neurophysiol (1993) 0.87
Human epidermal cells progressively lose their cardiolipins during ageing without change in mitochondrial transmembrane potential. Mech Ageing Dev (1994) 0.87
Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Pharmacoepidemiol Drug Saf (2001) 0.86
Dietary antioxidants, peroxidation and cardiovascular risks. J Nutr Health Aging (2002) 0.86
Effect of sleep deprivation on dopamine receptor function in normal subjects. J Neural Transm (1981) 0.86
N-Hexane- and methylethylketone-induced polyneuropathy. Abnormal accumulation of glycogen in unmyelinated axons. Report of a case. Acta Neuropathol (1981) 0.86
Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology (1996) 0.86
Detection and characterization of autoantibodies directed against neurofilament proteins in human African trypanosomiasis. Am J Trop Med Hyg (1997) 0.86
[Epilepsy and its impact in northwest region of the Central African Republic]. Med Trop (Mars) (1997) 0.85
[The ice storm: an opportunity to study the effects of prenatal stress on the baby and the mother.]. Sante Ment Que (2000) 0.85
Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma. J Clin Oncol (1998) 0.85
Clinical follow-up in the rat experimental model of African trypanosomiasis. Exp Biol Med (Maywood) (2003) 0.85
Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide. Cancer Chemother Pharmacol (1986) 0.85
Role of potassium channels and nitric oxide in the relaxant effects elicited by beta-adrenoceptor agonists on hypoxic vasoconstriction in the isolated perfused lung of the rat. Br J Pharmacol (1999) 0.84
Hypoxic pulmonary vasoconstriction. Gen Pharmacol (1999) 0.84
Increased plasma atrial natriuretic peptide after ingestion of low doses of ethanol in humans. Alcohol Clin Exp Res (1997) 0.84
[An efficacy trial on Trypanosoma brucei brucei of molecules permeating the blood-brain barrier and of megazol]. Bull Soc Pathol Exot (1994) 0.83
Disruption of endocrine rhythms in sleeping sickness with preserved relationship between hormonal pulsatility and the REM-NREM sleep cycles. J Biol Rhythms (1996) 0.83
Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France. Eur J Clin Pharmacol (2001) 0.83
[Neuropathies of unknown etiology. A study of 48 cases]. Rev Neurol (Paris) (1987) 0.82
[Contribution of computerized tomography in the diagnosis of cerebrovascular accidents in Nouakchott, Mauritania]. Med Trop (Mars) (2002) 0.82
[Seroprevalence of cysticercosis in the lacustrian community of Vekky, Atlantic district (Benin)]. Bull Soc Pathol Exot (1996) 0.82
[Neurologic forms of primary liver cancer (clinical and electroencephalographic study)]. Bull Soc Med Afr Noire Lang Fr (1968) 0.82
Pharmacokinetics, metabolism and excretion of megazol in a Trypanosoma brucei gambiense primate model of human African trypanosomiasis. Preliminary study. Arzneimittelforschung (2000) 0.82
Epilepsy, cysticercosis and neurocysticercosis in Benin. Eur Neurol (1998) 0.82
[Contribution of biochemical tests in the diagnosis of the nervous phase of human African trypanosomiasis]. Bull Soc Pathol Exot (1997) 0.82
[Role of glutamate and excitotoxicity in neurologic diseases]. Rev Neurol (Paris) (1996) 0.82
Protective effect of L-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin Biochem (2000) 0.82
Human African trypanosomiasis: presence of antibodies to galactocerebrosides. Am J Trop Med Hyg (1992) 0.82
Protective effect of L-cysteine and glutathione on rat brain Na+,K+-ATPase inhibition induced by free radicals. Z Naturforsch C (2000) 0.82
Sleep disruption following a marathon. J Sports Med Phys Fitness (1985) 0.81
[The detection of anti-galactocerebroside autoantibodies in human African trypanosomiasis]. Bull Soc Pathol Exot (1994) 0.81
Monitoring of the motor pathway during spinal surgery. Spine (Phila Pa 1976) (1993) 0.81
Effects of cold and capsaicin desensitization on prostaglandin E hypothermia in rats. J Appl Physiol (1985) (1990) 0.81
Retrograde axonal transport of nerve growth factor in the ciliary ganglion of the chick and the rat. Brain Res (1978) 0.81
Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium. Br J Pharmacol (2000) 0.81
Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells. Br J Cancer (1987) 0.81
Expression and function of neurotrophins and their receptors in human melanocytes. Int J Cosmet Sci (2006) 0.81
Retrograde transport of tetanus toxin through a chain of two neurons. Brain Res (1979) 0.81
[Cysticercosis in the province of Kayanza (Burundi)]. Bull Soc Pathol Exot (1992) 0.81
Familial Creutzfeldt-Jakob disease with extensive degeneration of white matter. Ultrastructure of peripheral nerve. J Neurol Sci (1983) 0.81
[Peritoneal tuberculosis and continuous ambulatory peritoneal dialysis]. Nephrologie (1993) 0.81
From a culture of blame to a culture of safety--the role of institutional ethics committees. Bioethics Forum (2001) 0.80
[Multiple sclerosis in Senegal]. Afr J Med Sci (1970) 0.80
[1st case of Wilson's disease in Senegal]. Bull Soc Med Afr Noire Lang Fr (1970) 0.80